相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acid β-Glucosidase Mutants Linked to Gaucher Disease, Parkinson Disease, and Lewy Body Dementia Alter α-Synuclein Processing
Valerie Cullen et al.
ANNALS OF NEUROLOGY (2011)
Translational Research in Neurology and Neuroscience 2011
Christine Klein et al.
ARCHIVES OF NEUROLOGY (2011)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases
Thai Leong Yap et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models
Y. H. Xu et al.
MOLECULAR GENETICS AND METABOLISM (2011)
CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Exploring the link between glucocerebrosidase mutations and parkinsonism
Wendy Westbroek et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
Ozlem Goker-Alpan et al.
ACTA NEUROPATHOLOGICA (2010)
The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
Arash Velayati et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)
Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease
Idit Ron et al.
HUMAN MOLECULAR GENETICS (2010)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies
L. Parnetti et al.
NEUROBIOLOGY OF DISEASE (2009)
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
W. C. Nichols et al.
NEUROLOGY (2009)
Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
Amy B. Manning-Bog et al.
NEUROTOXICOLOGY (2009)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
Murine models of acute neuronopathic Gaucher disease
Ida Berglin Enquist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease
L. N. Clark et al.
NEUROLOGY (2007)
Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
Chiara Balducci et al.
MOVEMENT DISORDERS (2007)
Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease
Raquel L. Lieberman et al.
NATURE CHEMICAL BIOLOGY (2007)
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
O. Goker-Alpan et al.
NEUROLOGY (2006)
Gaucher disease mouse models:: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
Y Sun et al.
JOURNAL OF LIPID RESEARCH (2005)
Gaucher disease: complexity in a simple disorder
E Sidransky
MOLECULAR GENETICS AND METABOLISM (2004)
Neuropathology provides clues to the pathophysiology of Gaucher disease
KD Wong et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
N Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2003)
The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease
R Sharon et al.
NEURON (2003)
分享论文
